Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors

SIMPLE SUMMARY: CD3-bispecific antibody therapy is a form of immunotherapy that enables soldier cells of the immune system to recognize and kill tumor cells. This type of therapy is currently successfully used in the clinic to treat tumors in the blood and is under investigation for tumors in our or...

Descripción completa

Detalles Bibliográficos
Autores principales: Middelburg, Jim, Kemper, Kristel, Engelberts, Patrick, Labrijn, Aran F., Schuurman, Janine, van Hall, Thorbald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829968/
https://www.ncbi.nlm.nih.gov/pubmed/33466732
http://dx.doi.org/10.3390/cancers13020287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829968/
https://www.ncbi.nlm.nih.gov/pubmed/33466732
http://dx.doi.org/10.3390/cancers13020287

Ejemplares similares